Very long-term clinical follow-up after fractional flow reserve-guided coronary revascularization

Journal of Invasive Cardiology

Volumn 24, Issue 7, 2012, Pages 309-315

  Miller, Louis H ^a   Toklu, Bora ^a   Rauch, Judah ^a   Lorin, Jeffrey D ^a   Lobach, Iryna ^a   Sedlis, Steven P ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

fractional flow reserve; percutaneous coronary intervention; pressure wire

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; EXERCISE TEST; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84864327811     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guide line update for percutaneous coronary intervention: A report of the American Col lege of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percu taneous Coronary Intervention). Accessed at: www.myamericanheart.org.
2. Mehta SR, Cannon CP, Fox KAA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes. JAMA. 2005;293(23):2908- 2917.
3. Shaw LJ, Berman DS, Maron DJ. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-1291. (Pubitemid 351365675)
4. Tonino, PAL, Fearon WF, De Bruyne B, et al. Angiographic versus function al severity of coronary artery stenosis in the FAME study. J Am Coll Cardiol. 2010;55(25):2816-2821.
5. Fischer JJ, Samady H, McPhearson JA, et al. Comparison between visual assess ment and quantitative angiography versus fractional flow reserve for native coro nary narrowings of moderate severity. Am J Cardiol. 2002;90(3):210-215. (Pubitemid 34804552)
6. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: The dissocia tion between clinical and angiographic findings in ischemia heart disease. Circula tion. 1999;92(8):2333-2342.
7. Pfisterer M, Brunner-La Rocca HP, Buser PT. Late clinical events after clopi dogrel discontinuation may limit the benefit of drug-eluting stents: An obser vational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48(12):2584-2591. (Pubitemid 44881238)
8. Tonino, PAL, De Bruyne B, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213-224.
9. Bech GJW, De Bruyne B, Pijls NHJ, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate artery stenosis: A randomized trial. Circulation. 2001;103(24):2928-2934. (Pubitemid 32578130)
10. Fearon WF, Bornschein B, Tonino PAL, et al. Economic evaluation of fractional flow reserve guided percutaneous coronary intervention in patients with multives sel disease. Circulation. 2010;122(24):2545-2550.
11. De Brunye B, Pijls NHJ, Barbato E, et al. Intracoronary and intravenous ad enosine 5 -triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation. 2003;107(14):1877-1883. (Pubitemid 36444128)
12. Pijls NHJ, Van Golder B, Van det Voort P, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92(11):3183-3195.
13. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634-2653. (Pubitemid 350182388)
14. Pijls NHJ, Fearon WF, Tonino PAL, et al. Fractional flow reserve versus angiogra phy for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. J Am Coll Cardiol. 2010;56(3):177-184.
15. Pijls NHJ, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary in tervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol. 2007;49(21):2105-2111. (Pubitemid 46771047)
16. Rieber J, Jung P, Koenig A, et al. Five-year follow-up in patients after thera py stratification based on intracoronary pressure measurement. Am Heart J. 2007;153(3):403-409. (Pubitemid 46328754)
17. Wongpraparut N, Yalamanchili V, Pasnoori V, et al. Thirty-month outcome after fractional flow resertve-guided versus conventional multivessel percutaneous coro nary intervention. Am J Cardiol. 2005;96(7):877-884. (Pubitemid 41362506)
18. De Lucca G, Venegoni L, Iorio S, Giuliani L, Marino P. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv. 2011;4(10):1079-1084.